Skip to main content
DNA Labs India

BARD1 Gene Breast cancer, susceptibility to NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

BARD1 Gene Breast cancer, susceptibility to NGS Genetic Test

Short Name: BARD1 Breast Cancer Susceptibility Test

Also known as: BARD1 Gene Mutation Test, Breast Cancer Genetic Susceptibility Test

BARD1 Gene Breast cancer, susceptibility to NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood, Extracted DNA, or FTA Card samples. Results in 3 to 4 weeks. Free home collection in 300+ cities across India.

NGS Genetic TestAdults🏠 Home Collection

✍️ Written By

🩺 Medically Reviewed By

Dr SULOCHANA HEMCHANDRA HOLLA

Dr SULOCHANA HEMCHANDRA HOLLA

Consultant Medical Geneticist · Reg: 8532

Last reviewed: September 7, 2026

Overview

The purpose of this test is to detect mutations in the BARD1 gene that may indicate an increased susceptibility to breast cancer. It aids in risk assessment, guides personalized medical management, and supports early intervention strategies.

Test Code
2849
Price
₹20,000
Sample Type
Blood, Extracted DNA, or FTA Card
Result Time
3 to 4 weeks
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

Provide detailed clinical history and undergo a genetic counseling session to draw a pedigree chart of family members affected with breast cancer. No fasting is required.

Method: Venipuncture

Step 2

Laboratory Analysis

A blood sample will be drawn by a trained phlebotomist using standard venipuncture techniques, or an alternative sample like extracted DNA or FTA card may be used.

Step 3

Report Delivery

Apply pressure to the puncture site to prevent bleeding. Resume normal activities immediately. Store samples as instructed if collected at home.

Timeline: 3 to 4 weeks

Patient Instructions

1
Before the Test:Schedule a genetic counseling session to discuss family history, test implications, and informed consent. No special preparation is needed.
2
During the Test:The test involves a simple blood draw or alternative sample collection, typically taking 10-15 minutes. The process is minimally invasive.
3
After the Test:Results will be available in 3-4 weeks. Follow up with your healthcare provider or genetic counselor to discuss findings and next steps.

About This Test

Who Should Get This Test

The purpose of this test is to detect mutations in the BARD1 gene that may indicate an increased susceptibility to breast cancer. It aids in risk assessment, guides personalized medical management, and supports early intervention strategies.

How to Prepare

  • Ensure proper patient identification
  • Use sterile collection equipment
  • Label samples accurately with patient details
  • Follow kit instructions for FTA card or DNA extraction

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Genetic testing for BARD1 mutations is crucial for individuals with a family history of breast cancer, enabling early intervention and personalized care strategies."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood, Extracted DNA, or FTA Card
Sample Volume5 mL blood (if applicable)
ContainerEDTA tube or FTA card
Collection MethodVenipuncture

Sample Stability

Blood: stable at room temperature for up to 48 hours
FTA card: stable at room temperature for extended periods when stored properly
Sample Rejection Criteria:
  • Hemolyzed or clotted blood sample
  • Insufficient sample volume
  • Incorrect sample container or labeling
  • Contaminated or degraded DNA

Understanding Your Results

Results indicate the presence or absence of pathogenic mutations in the BARD1 gene. A positive result suggests an increased genetic risk for breast cancer, while a negative result indicates no known mutations were detected.
📊

Positive for pathogenic variant

Increased risk of breast cancer. Recommend genetic counseling, enhanced screening, and discussion of preventive options with a healthcare provider.

📊

Negative for pathogenic variants

No known BARD1 mutations detected; risk may be similar to the general population. Continue routine screening based on other risk factors.

📊

Variant of Uncertain Significance (VUS)

Genetic variant identified but clinical significance unknown. Further testing, family studies, and genetic counseling are recommended.

⚠️ When to Consult a Doctor:

Consult a healthcare provider if you have a family history of breast cancer, receive a positive or VUS result, or experience symptoms such as breast lumps or changes. Genetic counseling is advised for all test results.

Limitations

  • ⚠May not detect all genetic variants or mutations
  • ⚠Variants of uncertain significance (VUS) may be identified
  • ⚠Does not rule out other genetic or environmental risk factors for breast cancer

Risks & Considerations

  • ●Minimal risk from blood draw, such as bruising, soreness, or rare infection
  • ●Potential psychological impact from results, including anxiety or stress
  • ●Risk of misinterpretation without proper genetic counseling

Interfering Factors

  • ●Sample contamination
  • ●Degraded DNA quality
  • ●Recent blood transfusion or stem cell transplant

Compare With Similar Tests

TestBARD1 Gene Breast cancer, susceptibility to NGS Genetic Test
ComparisonBARD1 Gene Breast cancer, susceptibility to NGS Genetic Test

Frequently Asked Questions

What is the BARD1 gene?
The BARD1 gene is located on chromosome 2 and encodes a protein involved in DNA repair and cell cycle regulation. Mutations in this gene are associated with an increased risk of breast cancer.
Who should consider the BARD1 Gene Breast Cancer Susceptibility Test?
Individuals with a family history of breast cancer, personal history of early-onset cancer, known BARD1 mutations in the family, or other risk factors like male breast cancer should consider this test.
How is the test performed?
The test uses next-generation sequencing (NGS) to analyze the BARD1 gene from a blood sample, extracted DNA, or FTA card. It identifies mutations or variations in the gene sequence.
What does a positive test result mean?
A positive result indicates a pathogenic mutation in the BARD1 gene, which increases the risk of developing breast cancer. It warrants genetic counseling and discussion of enhanced screening or preventive measures.
What does a negative test result mean?
A negative result means no known pathogenic mutations were detected in the BARD1 gene. However, it does not eliminate all breast cancer risk, as other genetic or environmental factors may be involved.
Is the test painful?
The test involves a standard blood draw, which may cause minor discomfort or bruising. It is generally well-tolerated and minimally invasive.
How long does it take to get results?
Results are typically available within 3 to 4 weeks after sample collection. You will be notified via online portal, email, or WhatsApp.
Is home sample collection available?
Yes, DNA Labs India offers free home sample collection for this test across many cities in India. You can book online for convenience.
What is the cost of the BARD1 Gene Test?
The cost is INR 20000, which includes sample collection, NGS analysis, genetic counseling report, and online report access.
Can men take this test?
Yes, the test is applicable to both men and women, as BARD1 mutations can increase breast cancer risk in males as well.
What are the risks of the test?
Risks are minimal and include those associated with blood draws, such as bruising. There may be psychological impacts from results, so genetic counseling is recommended.
What should I do after receiving results?
Consult a healthcare provider or genetic counselor to interpret results, understand implications, and plan for screening, prevention, or treatment as needed.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

Cancer Breast Comprehensive Panel Test

₹10,000

Breast comprehensive panel NGS Genetic Test

₹20,000
For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.